Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer
Authors
Keywords
Ovarian cancer, High-Grade Serous (HGS) cancer, APR-246 (PRIMA-1<sup>MET</sup>), Primary cancer cells, <em class=EmphasisTypeItalic >TP53</em> mutation, p53 reactivation, DNA-damaging drugs, Cisplatin, Doxorubicin, Synergy
Journal
Journal of Ovarian Research
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-05-15
DOI
10.1186/s13048-016-0239-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer treatment: The end of empiricism?
- (2015) Stephanie Lheureux et al. CANCER
- Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research
- (2015) Kevin M. Elias et al. GYNECOLOGIC ONCOLOGY
- Pharmacotherapy for recurrent ovarian cancer: current status and future perspectives
- (2015) K. Matsumoto et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells
- (2015) N Mohell et al. Cell Death & Disease
- Survival of patients with structurally-grouped TP53 mutations in ovarian and breast cancers
- (2015) Brandon-Luke L. Seagle et al. Oncotarget
- Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
- (2014) David L. Masica et al. HUMAN GENETICS
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
- (2013) Pavla Brachova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Glutathione in Cancer Progression and Chemoresistance
- (2013) Nicola Traverso et al. Oxidative Medicine and Cellular Longevity
- Precursors and pathogenesis of ovarian carcinoma
- (2013) D. Lim et al. PATHOLOGY
- APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase
- (2013) X Peng et al. Cell Death & Disease
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- PRIMA-1 increases cisplatin sensitivity in chemoresistant ovarian cancer cells with p53 mutation: a requirement for Akt down-regulation
- (2013) Noriko Kobayashi et al. Journal of Ovarian Research
- P53 and its molecular basis to chemoresistance in breast cancer
- (2012) Stian Knappskog et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin?
- (2010) Christopher G. Przybycin et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
- (2010) Yves Pommier et al. CHEMISTRY & BIOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
- (2009) J M R Lambert et al. ONCOGENE
- The fluorometric microculture cytotoxicity assay
- (2008) Elin Lindhagen et al. Nature Protocols
- PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
- (2008) J Shen et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now